Cognitive and Hormonal Treatment of Sex Offenders

This study has been terminated.
(too few patients participated)
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00379626
First received: September 21, 2006
Last updated: January 30, 2012
Last verified: January 2012

September 21, 2006
January 30, 2012
August 2003
August 2008   (final data collection date for primary outcome measure)
The degree of cognitive distortions after treatment [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • The degree of cognitive distortions, after treatnent(8 months)
  • The tesosterone levels before, under and after treatment each third month
Complete list of historical versions of study NCT00379626 on ClinicalTrials.gov Archive Site
  • Locus of control after treatment in part one. [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • Degree of mental health problems (SCL-90) [ Time Frame: 8 months ] [ Designated as safety issue: No ]
  • The testosterone levels before, during and after treatment [ Time Frame: baseline upto 8 months ] [ Designated as safety issue: No ]
    measured each 3rd month
  • Locus of control after treatment in part one.
  • Degree of mental health problems (SCL-90)
Not Provided
Not Provided
 
Cognitive and Hormonal Treatment of Sex Offenders
Cognitive Group and Hormonal Treatment of Sex Offenders.

The aim of this study is to determine if Cognitive treatment and hormone treatment can change the relapse rate of sexual offenders.

The aim of this study is to determine if Cognitive treatment and hormone treatment can change the relapse rate of sexual offenders.

In the first part of study we are studying changes in the offenders cognitive distortions and in the second part we are studying changes in sexual activities and sexual thoughts after treatment with Leuprorelin. The study is an open pre and post study.

Interventional
Phase 1
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Paraphilia
Drug: cognitive and hormone treatment
cognitive and hormone (Leuprorelin) treatment
Experimental: cognitive and hormone treatment
cognitive and hormone (Leuprorelin) treatment
Intervention: Drug: cognitive and hormone treatment
Nøttestad JA, Bjarnar E, Lundmo PI, Sandvik M. [Treatment of sex offenders with leuprorelin]. Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):633-4. Norwegian. No abstract available.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
5
August 2010
August 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

Men sentenced for paraphilia

Exclusion Criteria:

Men above 70 years and men that does not speak english

Male
18 Years to 70 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT00379626
AH 048-01
No
Norwegian University of Science and Technology
Norwegian University of Science and Technology
Not Provided
Principal Investigator: Jim Aa Nøttestad, Dr. Philos St. Olavs Hospital, Departement of forensic psychiatry, Brøset
Norwegian University of Science and Technology
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP